Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

By O. Lee, Tom K. Kuo, Wei-Ming Chen, Kuan-Der Lee, S. Hsieh, Tain-Hsiung Chen. Blood, 2004

1,285 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The stem-cell niche as an entity of action (2006, background): “HS cells might directly exploit their frequent blood trafficking to ‘survey’ input at a distance and some other stem-cell types might do the sam”
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. (2006, neutral): “isolation of cord blood-derived MSC are controversial.(14,16) In addition, the process of isolation of MSC is at the expense of losing”
Aging of mesenchymal stem cells. (2006, background): “Such cells can be isolated from umbilical cord blood (Lee et al., 2004; Hou et al., 2003), connective tissue (Young et al.”
Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy (2013, positive): “Many groups have reported that UCB has a maximum isolation efficiency of 65% in various culture methods; depletion of lymphocytes and monocyte from mononuclear cell (MNC) before cell seeding, addition of cytokines supplements or platelet lysate to the medium, or cultivation of cells under hypoxia [2”